 random trial levamisol versu placebo adjuv therapi malign melanoma long-term follow-up median year patient random trial levamisol versu placebo surgic adjuv therapi patient malign melanoma patient levamisol placebo result differ treatment control group regard end point disease-fre interv time appear viscer metastasi surviv signific differ treatment control group age sex stage diseas